AD/PD™ Webinar: Diagnosing Atypical Parkinsonism

Watch the recording of this session in the AD/PD™ Education portal!

This session brought together esteemed experts Stephen Gomperts, MD, PhD, Nikolaus McFarland, MD, PhD and Anne-Marie Wills, MD, MPH. The session was moderated by Prof. Werner Poewe.


  • Stephen N. Gomperts, MD, PhD, Associate Professor of Neurology, Harvard Medical School, board-certified neurologist, dementia and movement disorders specialist, and Director of the Lewy Body Dementia Unit at Massachusetts General Hospital
  • Nikolaus McFarland, MD, PhD, associate professor of neurology at the University of Florida Department of Neurology, board-certified neurologist and movement disorders specialist at the Norman Fixel Institute for Neurological Diseases at UF Health
  • Werner Poewe, MD, PhD, Professor of Neurology and Director of the Department of Neurology at Innsbruck Medical University in Innsbruck, Austria
  • Anne-Marie Wills, MD, MPH, board-certified neurologist at Massachusetts General Hospital and Director of the Mass General Progressive Supranuclear Palsy (PSP) Clinic

Learning Objectives

Through this session you will learn how to:

  1. Define the clinical criteria for diagnosing atypical Parkinsonism, specifically DLB, PSP, and MSA.
  2. Understand the biomarker criteria unique to each neurodegenerative disorder, enabling them to differentiate these from markers used in the diagnosis of Idiopathic PD.


Welcome & IntroductionsWerner Poewe 5 min
Dementia with Lewy Bodies (DLB) Stephen Gomperts 15 min
Progressive Supranuclear Palsy (PSP) Anne-Marie Wills 15 min
Multiple system atrophy (MSA) Nikolaus McFarland15 min
Q&A + Panel discussionAll speakers 20 min
Closing remarksWerner Poewe 5 min
NOTE! Please make sure you Log In or Register before you click this link.